High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas

Journal of Dermatological Science

Volumn 64, Issue 3, 2011, Pages 185-190

  Valencak, Julia ^a   Schmid, Katharina ^a   Trautinger, Franz ^b   Wallnöfer, Werner ^c   Muellauer, Leonhard ^a   Soleiman, Afschin ^a   Knobler, Robert ^a   Haitel, Andrea ^a   Pehamberger, Hubert ^a   Raderer, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

^c CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Dicer, microRNA; Primary cutaneous T cell lymphomas; Prognostic factor; Survival

Indexed keywords

DICER; MOLECULAR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; DEAD-BOX RNA HELICASES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHOMA, PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL; LYMPHOMA, T-CELL; LYMPHOMA, T-CELL, CUTANEOUS; LYMPHOMATOID PAPULOSIS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PANNICULITIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RIBONUCLEASE III; RISK ASSESSMENT; RISK FACTORS; SEZARY SYNDROME; SKIN NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 80055099998     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.08.011     Document Type: Article

References (25)

1. Lawrie C.H. MicroRNAs and haematology: small molecules, big function. Br J Haematol 2007, 137:503-512.
2. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
3. Nelson P., Kiriakidou M., Sharma A., Maniataki E., Mourelatos Z. The microRNA world: small is mighty. Trends Biochem Sci 2003, 28:534-540.
4. Sand M., Gambichler T., Sand D., Skrygan M., Altmeyer P., Bechara F.G. MicroRNAs and the skin: tiny players in the body's largest organ. J Dermatol Sci 2009, 53:169-175.
5. Rye P.D., Stigbrand T. Interfering with cancer: a brief outline of advances in RNA interference in oncology. Tumour Biol 2004, 25:329-336.
6. Merritt W.M., Lin Y.G., Han L.Y., Kamat A.A., Spannuth W.A., Schmandt R., et al. Dicer Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008, 359:2641-2650.
7. Karube Y., Tanaka H., Osada H., Tomida S., Tatematsu Y., Yanagisawa K., et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005, 96:111-115.
8. Aslam M.I., Taylor K., Pringle J.H., Jameson J.S. MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 2009, 96:702-710.
9. Sand M., Gambichler T., Sand D., Altmeyer P., Stuecker M., Bechara F. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic nevi. Eur J Dermatol 2011, 21:18-21.
10. Tchernitsa O., Kasajima A., Schäfer R., Kuban R., Ungethüm U., Györffy B., et al. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol 2010, 222:310-319.
11. Chiosea S., Jelezcova E., Chandran U., Luo J., Mantha G., Sobol R., et al. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 2007, 67:2345-2350.
12. Chiosea S.I., Barnes E.L., Lai S.Y., Egloff A.M., Sargent R.L., Hunt J.L., et al. Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression. Virchows Arch 2008, 452:629-635.
13. Grelier G., Voirin N., Ay A.S., Cox D.G., Chabaud S., Treilleux I., et al. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 2009, 101:673-683.
14. Van Kester M., Ballabio E., Benner M., Chen X., Saunders N., van der Fits L., et al. miRNA expression profiling of mycosis fungoides. Mol Oncol 2011, 5:273-280.
15. Ballabio E., Mitchell T., van Kester M., Taylor S., Dunlop H., Chi J., et al. MicroRNA expression in Sézary syndrome: identification, function, and diagnostic potential. Blood 2010, 116:1105-1113.
16. Sand M., Gambichler T., Skrygan M., Sand D., Scola N., Altmeyer P., et al. Expression levels of the microRNA processing enzymes Drosha and Dicer in epithelial skin cancer. Cancer Invest 2010, 28:649-653.
17. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005, 105:3768-3785.
18. Olsen E., Vonderheid E., Pimpinelli N., Willemze R., Kim Y., Knobler R., et al. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007, 110:1713-1722.
19. Kim Y.H., Willemze R., Pimpinelli N., Whittaker S., Olsen E.A., Ranki A., et al. ISCL and the EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer. Blood 2007, 110:479-484.
20. Chiosea S., Jelezcova E., Chandran U., Luo J., Mantha G., Sobol r., et al. Overexpression of Dicer in precursor lesions of lung adenocarcinomas. Cancer Res 2007, 67:2345-2350.
21. Chiosea S., Jelezcova E., Chandran U., Acquafondata M., McHale T., Sobol R.W., et al. Up-regulation of Dicer, a component of the microRNA machinery, in prostate adenocarcinoma. Am J Pathol 2006, 169:1812-1820.
22. Sugito N., Ishiguro H., Kuwabara Y., Kimura M., Mitsui A., Kurehara H., et al. RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 2006, 12:7322-7328.
23. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003, 17:3011-3016.
24. Vidulich K.A., Talpur R., Bassett R.L., Duvic M. Overall survival in erythrodermic cutaneous T cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T cell lymphoma. Int J Dermatol 2009, 48:243-252.
25. Poligone B., Wilson L.D., Subtil A., Heald P. Primary cutaneous T cell lymphoma localized to the lower leg: a distinct, locally aggressive cutaneous T cell lymphoma. Arch Dermatol 2009, 145:677-682.